Beryl Drugs Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹6.29Cr |
Net Profits | ₹0.37Cr |
Net Profit Margins | 5.88% |
Highlights
Revenue:
Beryl Drugs Ltd’s revenue fell -23.01% since last year same period to ₹6.29Cr in the Q1 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 95.95% jump in its revenue since last 3-months.
Net Profits:
Beryl Drugs Ltd’s net profit fell -30.19% since last year same period to ₹0.37Cr in the Q1 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 205.71% jump in its net profits since last 3-months.
Net Profit Margins:
Beryl Drugs Ltd’s net profit margin fell -9.32% since last year same period to 5.88% in the Q1 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 153.95% jump in its net profit margins since last 3-months.
